限制性胸部对肺移植后的长期肺功能参数的影响,在患有间歇性肺病的患者中
Keita Nakanishi1,2, Thomas Schweiger1, Stefan Schwarz1
1Department of Thoracic Surgery, Medical University of Vienna, Vienna, Austria.
概括
在间歇性肺病 (ILD) 患者的肺移植 (LTx) 结果与胸部限制无关,结果相似. 术前胸腔大小不会显著影响长期肺功能或LTx后的存活率.
科学领域:
- 肺部医学 肺部医学
- 胸部外科手术 胸部外科手术
- 移植免疫学 移植免疫学
背景情况:
- 间歇性肺病 (ILD) 导致慢性肺收缩,导致隔膜升高.
- 胸部限制的程度在ILD患者之间有所不同,影响了肺移植 (LTx) 候选人和结果.
- 术前胸腔体积 (实际与预测的肺总容量比率) 与ILD中的LTx结果之间的关系尚不清楚.
研究的目的:
- 调查手术前胸腔限制对ILD患者肺功能和LTx后生存的影响.
- 为了比较ILD患者之间的术后和长期结果,具有低和高的实际和预测的肺总容量比率.
- 评估胸壁合规性对ILD中LTx结果的影响.
主要方法:
- 在欧洲中心对ILD患者进行170次LTx手术的回顾性分析 (09/2011-12/2022).
- 根据手术前实际与预测的肺总容量比率,患者分为两组:低 (<0.55) 和高 (≥0.55).
- 术后参数 (通风,ICU/住院) 和长期结果 (肺功能,生存) 的比较.
主要成果:
- 在气管切除术,再输管,机械通风持续时间或ICU/住院期间,两组之间没有显著差异.
- 在高a/pTLC比率组中,早期术后肺功能更好,但长期差异并不显著.
- 低A/PTLC比率和高A/PTLC比率组之间的五年整体生存率是可比的.
结论:
- 虽然在技术上具有挑战性,但在胸部受限的ILD患者中的LTx显示了与胸部保存患者相比类似的外科术后过程.
- 在接受LTx的ILD患者中,术前胸部限制的程度不会显著影响长期肺功能和整体存活率.
- 结果表明,改善胸壁的遵守可能会减轻手术前限制对LTx结果的影响.
更多相关视频
09:54Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
1.7K
06:15Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
Published on: November 10, 2023
812
相关概念视频
Pneumothorax-II
120
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
120
Lung Capacity
49.3K
The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
49.3K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chest Physiotherapy
382
Chest Physiotherapy (CPT) is a therapeutic technique used in respiratory care to improve ventilation, clear bronchial secretions, and enhance the efficiency of respiratory muscles. This therapy includes three primary procedures: postural drainage, percussion, and vibration. It can be performed on spontaneously breathing patients and those who are intubated and mechanically ventilated.
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
382
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
